Top compounds associated with response to ERVK3-1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	tipifarnib	CTRPv2	pan-cancer	AAC	-0.029	0.4
mRNA	PDMP	CTRPv2	pan-cancer	AAC	-0.035	0.4
mRNA	BRD-K30019337	CTRPv2	pan-cancer	AAC	0.069	0.4
mRNA	BRD-K27188169:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.047	0.4
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.03	0.4
mRNA	CAL-101	CTRPv2	pan-cancer	AAC	-0.033	0.4
mRNA	dabrafenib	CTRPv2	pan-cancer	AAC	0.043	0.4
mRNA	momelotinib	CTRPv2	pan-cancer	AAC	-0.031	0.4
mRNA	BRD-K33199242	CTRPv2	pan-cancer	AAC	-0.034	0.4
mRNA	AZD6244	CTRPv2	pan-cancer	AAC	-0.032	0.4

Download CSV